Alamar Biosciences (ALMR) vs Revvity (RVTY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Revvity is the larger company by market cap ($17.20 billion vs $1.75 billion), about 9.8 times the size. Revvity pays a dividend yielding 0.18%, while Alamar Biosciences does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALMR | RVTY |
|---|---|---|
| Share price | $25.27 | $154.18 |
| Market cap | $1.75B | $17.20B |
| 1-day change | -2.47% | +1.33% |
| YTD return | — | +59.36% |
| 1-year return | — | +68.21% |
| 5-year return | — | -10.40% |
| P/E ratio (TTM) | — | 72.73 |
| Forward P/E | — | 26.18 |
| EPS (TTM) | $-1.17 | $2.12 |
| Dividend yield | 0.00% | 0.18% |
| Annual dividend | $0.00 | $0.28 |
| Revenue (latest FY) | — | $2.86B |
| Revenue growth (YoY) | — | +3.67% |
| Net income (latest FY) | — | $241.20M |
| Operating margin | — | 12.49% |
| Net margin | — | 8.45% |
| 52-week high | $39.61 | $166.25 |
| 52-week low | $18.85 | $81.22 |
| Distance from 52-week high | -36.20% | -7.26% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +40.09% | -11.88% |
| Average volume | 413.76K | 1.79M |
| Shares outstanding | 69.39M | 111.59M |
| Employees | 286 | 11,000 |
| Sector | Industrials | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Revvity is about 9.8 times larger than Alamar Biosciences by market value ($17.20B vs $1.75B).
About Alamar Biosciences
ALMR stock →Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers.
Industrials · Biotechnology: Laboratory Analytical Instruments · 286 employees
About Revvity
RVTY stock →Revvity, Inc. provides health sciences solutions, technologies, and services.
Industrials · Biotechnology: Laboratory Analytical Instruments · 11,000 employees
ALMR vs RVTY FAQ
Which is bigger, Alamar Biosciences or Revvity?
Revvity (RVTY) is larger, with a market capitalization of $17.20B compared with $1.75B for Alamar Biosciences (ALMR).
Which pays a higher dividend, Alamar Biosciences or Revvity?
Revvity pays a dividend yielding 0.18%, while Alamar Biosciences does not currently pay a regular dividend.
Are Alamar Biosciences and Revvity in the same industry?
Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.